RECRUITINGINTERVENTIONAL
A Pilot Study of Synbiotics in Adults With Depressive Symptoms
A Pilot Study on the Efficacy of a Synbiotic Formula (MQU10) in Improving Mood and Well-being in Adults With Mild to Moderate Depressive Symptoms
About This Trial
This study aims to explore the efficacy and safety of a synbiotic formula (MQU10) in improving mood and well-being in adults with mild to moderate depressive symptoms.
Who May Be Eligible (Plain English)
Who May Qualify:
- Individuals aged 18 or above
- Patient Health Questionnaire-9 (PHQ-9) score between 5 to 14
- Literate and can complete the self-report questionnaires
- Able to understand the consent and sign the willing to sign a consent form form
Who Should NOT Join This Trial:
- Current diagnosis of substance abuse or dependence;
- A current or past history of bipolar disorder, manic or hypomanic episodes, schizophrenia, personality disorder, posttraumatic stress disorder (PTSD), intellectual disability, neurodegenerative disorders (e. g, Parkinson's disease) or organic mental disorder
- Requiring immediate psychiatric care (e. g, imminently suicidal subjects) or have attempted suicide in the past 3 months
- Use of antipsychotics, antidepressants or sedatives, unless on a stable dose in the last 4 weeks
- History of severe organ failure, renal failure on dialysis, HIV infection
- Active malignancy within 5 years
- History of major surgery on the gastrointestinal tract, except cholecystectomy and appendectomy in the past 5 years
- Night shift work
- History of antibiotic use within 4 weeks
- History of allergy to probiotics or lactose leading to a severe allergic reaction
- Known pregnancy or lactating
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Individuals aged 18 or above
* Patient Health Questionnaire-9 (PHQ-9) score between 5 to 14
* Literate and can complete the self-report questionnaires
* Able to understand the consent and sign the informed consent form
Exclusion Criteria:
* Current diagnosis of substance abuse or dependence;
* A current or past history of bipolar disorder, manic or hypomanic episodes, schizophrenia, personality disorder, posttraumatic stress disorder (PTSD), intellectual disability, neurodegenerative disorders (e. g, Parkinson's disease) or organic mental disorder
* Requiring immediate psychiatric care (e. g, imminently suicidal subjects) or have attempted suicide in the past 3 months
* Use of antipsychotics, antidepressants or sedatives, unless on a stable dose in the last 4 weeks
* History of severe organ failure, renal failure on dialysis, HIV infection
* Active malignancy within 5 years
* History of major surgery on the gastrointestinal tract, except cholecystectomy and appendectomy in the past 5 years
* Night shift work
* History of antibiotic use within 4 weeks
* History of allergy to probiotics or lactose leading to a severe allergic reaction
* Known pregnancy or lactating
Treatments Being Tested
DIETARY_SUPPLEMENT
MQU10
MQU10 consists of a blend of food-grade probiotic strains (20 billion CFU daily) and prebiotic compounds.
Locations (2)
GenieBiome Limited
Hong Kong, Hong Kong
Healthymind Centre
Hong Kong, Hong Kong